Reporting owner · CIK 0001191249
Laviolette Paul A
SEC Form 4 history across 2 companies, 3 transactions and 3 filings.
CEOChief Executive OfficerPULSE BIOSCIENCES, INC.
Open-market transaction mix100% buys2 buys · 0 sales
Available history · May 08, 2026 – May 11, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
PLSEPULSE BIOSCIENCES, INC. | Laviolette Paul ACEO | P · buyAmended filingSEC filing ↗ | $295kView disclosure → | |
PLSEPULSE BIOSCIENCES, INC. | Laviolette Paul ACEO | P · buySEC filing ↗ | $295kView disclosure → | |
EWEdwards Lifesciences Corp | Laviolette Paul ADIR | A · grantSEC filing ↗ | $0View disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
buy at PULSE BIOSCIENCES, INC. on May 11, 2026 valued at $295,350.
Review SEC filingLatest sale
No open-market insider sale is available.
Monthly open-market activity
Last 1 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 2 | 0 | $590,700.00 | $0.00 | $590,700.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$295.4K
Median P/S size$295.4K
Direct3
Indirect0
May 11, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Scope is the available history shown in this profile.
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
2 observations · May 11, 2026 – May 11, 2026. Window ends at the latest available report, not today.
Selected observation · May 11, 202615,846 shares reportedAmended filing
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 11, 2026 | 15,000 | May 11, 2026 | View transaction |
| May 11, 2026 | 15,846 | May 12, 2026 | Amended transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Laviolette Paul A Insider Activity FAQ
SEC Form 4 context
Who is Laviolette Paul A?
Laviolette Paul A is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001191249.
Which companies has Laviolette Paul A reported transactions for?
PULSE BIOSCIENCES, INC., Edwards Lifesciences Corp
When was Laviolette Paul A's latest insider buy?
buy at PULSE BIOSCIENCES, INC. on May 11, 2026 valued at $295,350.
When was Laviolette Paul A's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.